NEWS
![[Hankyung] C&R Research “Enter Into The U.S. Clinical Agency Market Within The Year”](http://www.cnrres.com/wp-content/uploads/2021/04/CR-CI_홈페이지-기사-업로드용-300x200.png)
[Hankyung] C&R Research “Enter into the U.S. clinical agency market within the year”
2023-08-14
Vision for Korea’s ‘No. 1’ CRO company Established a local branch and received project orders Standardize your data with your…
[Etoday] C&R Research expands performance in the first half of the year… Sales KRW 25.6 billion
2023-08-14
C&R Research, a clinical trial consignment agency, achieved its highest performance since listing. C&R Research announced on the 14th that…
[Hankyung] C&R Research helps develop treatments for rare diseases through ‘external control group’
2023-07-27
C&R Research, Korea's first contract research organization (CRO) company, supports the development of treatments for rare and incurable diseases…
[Edaily] C&R Research selected for government task related to standardization of clinical trial data
2023-07-27
C&R Research (359090) (CEO Moon-Tae Yoon), Korea's largest clinical trial consignment agency, is carrying out 'data standardization and application tasks…
[Sedaily] “Re-pursuing the acquisition of a Clinical Trial consignment agency… Taking the lead to Decentralized Clinical Trial.”
2023-06-20
“For a domestic blockbuster new drug to be created, domestic contract research organizations (CROs) must first secure global-level capabilities. This…